Ionis Pharmaceuticals, Inc. (IONS) Operating cash flow 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$268.6MFY2025 · since FY2016: -$112.1M → -$268.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$268.6M | +46.4% |
| FY2024 | -$500.9M | -62.9% |
| FY2023 | -$307.5M | -12.1% |
| FY2022 | -$274.4M | -990.8% |
| FY2021 | $30.8M | -14.2% |
| FY2020 | $35.9M | -89.6% |
| FY2019 | $345.6M | -42.7% |
| FY2018 | $602.9M | +246.2% |
| FY2017 | $174.1M | +255.3% |
| FY2016 | -$112.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Gross marginIONS Operating incomeIONS Operating marginIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Total liabilitiesIONS Shareholders’ equityIONS overview →